Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis

Blood

Volumn 116, Issue 15, 2010, Pages 2857-2858

  Passamonti, Francesco ^a   Cervantes, Francisco ^b   Vannucchi, Alessandro Maria ^c,d   Morra, Enrica ^e   Rumi, Elisa ^a   Cazzola, Mario ^a   Tefferi, Ayalew ^f  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ISTITUTO TOSCANO TUMORI   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BLAST CELL; BLAST CELL CRISIS; BLOOD TRANSFUSION; CANCER GROWTH; CELL TRANSFORMATION; DYNAMIC INTERNATIONAL PROGNOSTIC SCORING SYSTEM; ERYTHROCYTE LIFESPAN; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MYELOID METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL TIME; THROMBOCYTE COUNT; ADULT; AGED; BLOOD; COMPLICATION; DISEASE COURSE; FEMALE; KAPLAN MEIER METHOD; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRIMARY MYELOFIBROSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 77957955039     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-06-293415     Document Type: Letter

References (10)

1. Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood. 2005;105(3):973-977. (Pubitemid 40170863)
2. Thoennissen NH, Krug UO, Lee DH, et al. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood. 2010;115(14):2882-2890.
3. Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2009;113(13):2895-2901.
4. Tam CS, Abruzzo LV, Lin KI, et al. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. Blood. 2009;113(18):4171-4178.
5. Morel P, Duhamel A, Hivert B, Stalniekiewicz L, Demory JL, Dupriez B. Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients. Blood. 2010;115(22):4350-4355.
6. Tam CS, Kantarjian H, Cortes J, et al. Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis. J Clin Oncol. 2009;27(33):5587-5593.
7. Passamonti F, Rumi E, Elena C, et al. Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence [published online ahead of print June 15, 2010]. Br J Haematol. doi:10.1111/j.1365-2141.2010. 08275.x.
8. Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Dewald GW. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol. 2001;113(3):763-771. (Pubitemid 32524401)
9. Tefferi A, Lasho TL, Huang J, et al. Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia. 2008;22(4):756-761. (Pubitemid 351559282)
10. Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 2010;115(9):1703-1708.